GHRP-6 CAS NO.87616-84-0

Min.Order: 0 Metric Ton
Payment Terms:

Product Details

Keywords

GHRP-6
GHRP-SIX
GHRP

Quick Details

ProName: GHRP-6
CasNo: 87616-84-0
Molecular Formula: C46H56N12O6
Appearance: Lyophilzed white powder
Application: Research use only
ProductionCapacity: Metric Ton/Day
Purity: 98%
Storage: -20℃
LimitNum: 0 Metric Ton

Superiority

Sequence:

H-His-D-Trp-Ala-Trp-D-Phe-Lys-NH2

FM: C46H56N12O6

MW: 873.01

Storage: Store at -20C. Keep container tightly closed. Store in a cool dry place.

Appearance: Lyophilzed white powder

The product list:

Melanotan-II (MT-II)

GHRP-6

Thymosin beta 4 (TB500)

HGH Powder

Trenbolone enanthate

HGH176-191 (HGH fragment) PT-141

CJC-1295 NO DAC Metandienone

GHRP-2 CJC-1295 with DAC

Ipamorelin Hexarelin

MGF Boldenone

Follistatin Trenbolone cyclohexylmethylcarbonate

IGF-1 LR3 Testosterone

Boldenone undecylenate Testosterone undecanoate

Nandrolone decanoate Testosterone phenylpropionate

Turinabol Testosterone Isocaproate

Trenbolone Acetate Tadalafil (Cialis)

Testosterone propionate Stanozolol Coarse (Winstrol)

Testosterone enanthate Sildenafil(Viagra)

Testosterone cypionate Nolvadex

Tamoxifen Citrate Nandrolone

Stanozolol Micronized (Winstrol) Nandrolone phenylpropionate

Oxymetholone (Anadrol) Methyltrienolone

Oxandrolone (Anavar) Methyl-testosterone

Methenolone Enanthate Mesterolone(Proviron)

Methenolone Acetate Letrozole (Femara)

Methandrostenolone (Dianabol) Formestane

Drostanolone propionate (Masteron) Fluoxymesterone(halotesin)

Testosterone-Sustanon250 Exemestane (Aromasin)

Anastrozole (Arimidex) Drostanolone enanthate

Testosterone decanoate Clomiphene Citrate(Clomid)

17a-Methyl-1-Testosterone 4-Chlorotestosterone acetate

Details

GHRP-6, a peptide with sequence H(d-W)AW(d-F)K-NH2, is a ghrelin receptor agonist, which has previously been reported to increase gastric emptying in normal rats. A study investigated the prokinetic effect of GHRP-6 in a mouse model of diabetes mellitus have shown that GHRP-6 can accelerate delayed gastric emptying (GE) and intestinal transit (IT), but has no effect on colonic transit (CT) in diabetic mice, which implied that GHRP-6 may exert its prokinetic effects via the cholinergic pathway in the enteric nervous system, and therefore, may have therapeutic potential for diabetic patients with delayed upper gastrointestinal transit.